Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04896658 · TERMINATED
Trial details
- NCT number
- NCT04896658
- Sponsor
- University of Maryland, Baltimore
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.